Commodity Chemicals company Deepak Nitrite announced Q1FY26 results Total Income: Rs 1,897 crore compared to Rs 2,186 crore during Q1FY25, change -13%. EBITDA: Rs 197 crore compared to Rs 328 crore during Q1FY25, change -40%. PAT: Rs 138 crore compared to Rs 275 crore during Q1FY25, change -50%. Deepak C. Mehta, Chairman & Managing Director, said: The first quarter of FY26 has reinforced our belief that ‘Destination Bharat’ is not just a strategic choice but a resilient foundation for continued long-term growth of our business. Amidst a volatile geopolitical environment marked by shifting global trade dynamics and elevated tariffs, Deepak continues to benefit from its India-centric, import-substitution-led business model. Domestic consumption remains robust, and our backward and forward integration strategy is proving effective in helping us navigate pricing pressures and demand fluctuations across global markets. Our Phenolics segment, powered by favourable domestic demand, continues to excel, laying a solid foundation for future growth. Concurrently, our AI segment is emerging from a period of global headwinds. We are channelling our resources to accelerate strategic initiatives that will not only help us weather current market conditions but also position us at the forefront of the next wave of industry innovation. This unwavering focus on our long-term vision ensures we are building a more resilient and forward-looking enterprise. We stand at the threshold of a transformative phase, marked by giant leaps in industry leadership, strategic technology partnerships, and large-scale CAPEX initiatives. Multiple projects are currently underway, some successfully commercialised, with a robust pipeline scheduled for rollout over the coming quarters. These initiatives span a wide spectrum of objectives, including capacity expansion, securing stable input supplies, and driving both backward integration for production efficiency as well as forward integration into new product lines. Our renewable energy transition, which began yielding tangible benefits in March 2025, is already enhancing energy security and strengthening the sustainability footprint across operations. Collectively, these efforts are set to deepen integration across our value chain and significantly elevate our competitive positioning in the market. Our unwavering commitment to innovation, import substitution, and global market expansion continues to strengthen our agility and responsiveness to the evolving needs of our customers. Looking ahead, we are confident that Deepak’s deeply integrated and scalable business model is uniquely positioned to play a pivotal role in shaping a self-reliant chemical ecosystem for a Viksit Bharat. Result PDF
Specialty Chemicals company Galaxy Surfactants announced Q1FY26 results Total Revenue: Rs 1,289.2 crore compared to Rs 979.5 crore during Q1FY25, change 31.6%. EBITDA: Rs 135.1 crore compared to Rs 129.5 crore during Q1FY25, change 4.3% EBITDA Margin: 10.5% for Q1FY26. PAT: Rs 79.5 crore compared to Rs 79.7 crore during Q1FY25, change -0.3%. PAT Margin: 6.2% for Q1FY26. K. Natarajan, Managing Director, Galaxy Surfactants, said: “Q1FY26 Volume grew at 5% YoY and nearly double-digit sequential growth across both performance and speciality care segments, reflecting a sign of improvement across all regions. India’s domestic performance reflects a market in transition and evolution, with flat YoY and double-digit QoQ volume growth. Strategic product adjustments in response to multinational shifts, coupled with favourable macro factors such as a good monsoon, rate cuts, and rural stimulus, support a cautiously optimistic outlook. In AMET, while Egypt and Turkey faced headwinds, resilience in the Gulf and Sub-Saharan markets helped maintain momentum. Our supply chains adapted swiftly despite geopolitical tensions, ensuring continuity and responsiveness. ROW region led growth with a strong 16% YoY increase, driven by LATAM and APAC, while Europe delivered a richer product mix aligned with our Vision 2030. Supply-side challenges persisted with tight raw material availability and regional congestion, but price pass-through mechanisms and inventory vigilance helped mitigate the impact. As we reaffirm our long-term strategy, we remain focused on innovation, agility, and sustainability, confident in our ability to navigate current complexities and deliver enduring value to all stakeholders.” Result PDF
Specialty Chemicals company Anupam Rasayan India announced Q1FY26 results Total revenue for Q1FY26 was at Rs 4,907 million as compared to Rs 2,603 million in Q1FY25; up 89% YoY. EBITDA (incl. other income) was at Rs 1,292 million in Q1FY26 as compared to Rs 592 million in Q1FY25, up 118% and this would translate into 26% EBITDA margin in this quarter. Profit After Tax was at Rs 485 million in Q1FY26 as compared to Rs 122 million in Q1FY25; up 297% YoY. Anand Desai, Managing Director, Anupam Rasayan, said: “During Q1FY26, consolidated revenue stood at Rs 491 crore, registering a robust growth of 89% year-on-year. We strongly believe that the sectoral trends are in our favour, and we are witnessing a clear resurgence in growth. Our pharma and polymer businesses are performing well, coupled with a recovery in the Agrochemical segment. The USA and Japan markets have shown encouraging trends for Anupam Rasayan. During Q1FY26, total exports accounted for 58% of the total revenue from operations. With the two new agreements signed with Japanese and US-based multinational companies, our order book now stands at Rs 14,646 crore, reflecting the strong growth momentum in our business.” Result PDF